|
1
|
Zhang P, Zhang H, Han X, Di J, Zhou Y, Li
K and Zheng QI: Effectiveness and safety of laparoscopic Roux-en-Y
gastric bypass for the treatment of type 2 diabetes mellitus. Exp
Ther Med. 11:827–831. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wild S, Roglic G, Green A, Sicree R and
King H: Global prevalence of diabetes: Estimates for the year 2000
and projections for 2030. Diabetes Care. 27:1047–1053. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cunningham CM, Larzelere ED and Arar I:
Conventional microscopy vs. computer imagery in chiropractic
education. J Chiropr Educ. 22:138–144. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mocanu AO, Mulya A, Huang H, Dan O,
Shimizu H, Batayyah E, Brethauer SA, Dinischiotu A and Kirwan JP:
Effect of Roux-en-Y gastric bypass on the NLRP3 inflammasome in
adipose tissue from obese rats. PLoS One. 10:e01397642015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wild S, Roglic G, Green A, Sicree R and
King H: Global prevalence of diabetes: Estimates for the year 2000
and projections for 2030. Diabetes Care. 27:1047–1053. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Boza C, Muñoz R, Salinas J, Gamboa C,
Klaassen J, Escalona A, Pérez G, Ibañez L and Guzmán S: Safety and
efficacy of Roux-en-Y gastric bypass to treat type 2 diabetes
mellitus in non-severely obese patients. Obes Surg. 21:1330–1336.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gloy VL, Briel M, Bhatt DL, Kashyap SR,
Schauer PR, Mingrone G, Bucher HC and Nordmann AJ: Bariatric
surgery versus non-surgical treatment for obesity: A systematic
review and meta-analysis of randomised controlled trials. BMJ.
347:f59342013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jørgensen CH, Gislason GH, Andersson C,
Ahlehoff O, Charlot M, Schramm TK, Vaag A, Abildstrøm SZ,
Torp-Pedersen C and Hansen PR: Effects of oral glucose-lowering
drugs on long term outcomes in patients with diabetes mellitus
following myocardial infarction not treated with emergent
percutaneous coronary intervention-a retrospective nationwide
cohort study. Cardiovasc Diabetol. 9:542010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Buchwald H and Williams SE: Bariatric
surgery worldwide 2003. Obes Surg. 14:1157–1164. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
DePaula AL, Macedo AL, Mota BR and
Schraibman V: Laparoscopic ileal interposition associated to a
diverted sleeve gastrectomy is an effective operation for the
treatment of type 2 diabetes mellitus patients with BMI 21–29. Surg
Endosc. 23:1313–1320. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pories WJ, Swanson MS, MacDonald KG, Long
SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal
JM, et al: Who would have thought it? An operation proves to be the
most effective therapy for adult-onset diabetes mellitus. Ann Surg.
222:339–352. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Buchwald H, Avidor Y, Braunwald E, Jensen
MD, Pories W, Fahrbach K and Schoelles K: Bariatric surgery: A
systematic review and meta-analysis. JAMA. 292:1724–1737. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schauer PR, Burguera B, Ikramuddin S,
Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R,
Barinas-Mitchel E, et al: Effect of laparoscopic Roux-en Y gastric
bypass on type 2 diabetes mellitus. Ann Surg. 238:467–485.
2003.PubMed/NCBI
|
|
14
|
Wang TT, Hu SY, Gao HD, Zhang GY, Liu CZ,
Feng JB and Frezza EE: Ileal transposition controls diabetes as
well as modified duodenal jejunal bypass with better lipid lowering
in a nonobese rat model of type II diabetes by increasing GLP-1.
Ann Surg. 247:968–975. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Robinson SW, Dinulescu DM and Cone RD:
Genetic models of obesity and energy balance in the mouse. Annu Rev
Genet. 34:687–745. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu J, Hou SS, Wang W, Yin M, Cheng N, Ge
LL, Yin JJ and Xu J: Hepatic phosphoenolpyruvate carboxykinase
expression after gastric bypass surgery in rats with type 2
diabetes mellitus. Genet Mol Res. 14:16938–16947. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Samuel VT, Beddow SA, Iwasaki T, Zhang XM,
Chu X, Still CD, Gerhard GS and Shulman GI: Fasting hyperglycemia
is not associated with increased expression of PEPCK or G6Pc in
patients with type 2 diabetes. Proc Natl Acad Sci USA.
106:12121–12126. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vander Kooi BT, Onuma H, Oeser JK, Svitek
CA, Allen SR, Vander Kooi CW, Chazin WJ and O'Brien RM: The
glucose-6-phosphatase catalytic subunit gene promoter contains both
positive and negative glucocorticoid response elements. Mol
Endocrinol. 19:3001–3022. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Haber BA, Chin S, Chuang E, Buikhuisen W,
Naji A and Taub R: High levels of glucose-6-phosphatase gene and
protein expression reflect an adaptive response in proliferating
liver and diabetes. J Clin Invest. 95:832–841. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Z, Barrett EJ, Dalkin AC, Zwart AD and
Chou JY: Effect of acute diabetes on rat hepatic
glucose-6-phosphatase activity and its messenger RNA level. Biochem
Biophys Res Commun. 205:680–686. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sesti G, Federici M, Hribal ML, Lauro D,
Sbraccia P and Lauro R: Defects of the insulin receptor substrate
(IRS) system in human metabolic disorders. FASEB J. 15:2099–2111.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bjornholm M, Kawano Y, Lehtihet M and
Zierath JR: Insulin receptor substrate-1 phosphorylation and
phosphatidylinositol 3-kinase activity in skeletal muscle from
NIDDM subjects after in vivo insulin stimulation. Diabetes.
46:524–527. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gatmaitan P, Huang H, Talarico J,
Moustarah F, Kashyap S, Kirwan JP, Schauer PR and Brethauer SA:
Pancreatic islet isolation after gastric bypass in a rat model:
Technique and initial results for a promising research tool. Surg
Obes Relat Dis. 6:532–537. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stygar D, Sawczyn T, Skrzep-Poloczek B,
Karcz-Socha I, Doleżych B, Zawisza-Raszka A, Augustyniak M,
Żwirska-Korczala K and Karcz WK: Ileal transposition in rats
influenced glucose metabolism and HSP70 levels. Open Life Sci.
10:278–284. 2015.
|
|
25
|
Kodama Y, Zhao CM, Kulseng B and Chen D:
Eating behavior in rats subjected to vagotomy, sleeve gastrectomy,
and duodenal switc. J Gastrointest Surg. 14:1502–1510. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang S, Jiao YB, Wang Y, Zou ZD, Zhang
ZZ, Wang YB and Dai LJ: Long-term efficacy of gastric bypass on
non-obese type 2 diabetes mellitus in Goto-Kakizaki rat. Chin J
Clin. 5:2011.
|
|
27
|
Yin DP, Gao Q, Ma LL, Yan W, Williams PE,
McGuinness OP, Wasserman DH and Abumrad NN: Assessment of different
bariatric surgeries in the treatment of obesity and insulin
resistance in mice. Ann Surg. 254:73–82. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lupi R and Del Prato S: Beta-cell
apoptosis in type 2 diabetes: Quantitative and functional
consequences. Diabetes Metab. 34 Suppl 2:S56–S64. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rubino F, Schauer PR, Kaplan LM and
Cummings DE: Metabolic surgery to treat type 2 diabetes: Clinical
outcomes and mechanisms of action. Annu Rev Med. 61:393–411. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schauer PR, Bhatt DL, Kirwan JP, Wolski K,
Brethauer SA, Navaneethan SD, Aminian A, Pothier CE, Kim ES, Nissen
SE, et al: Bariatric surgery versus intensive medical therapy for
diabetes-3-year outcomes. N Engl J Med. 370:2002–2013. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cohen RV, Schiavon CA, Pinheiro JS, Correa
JL and Rubino F: Duodenal-jejunal bypass for the treatment of type
2 diabetes in patients with body mass index of 22–34
kg/m2: A report of 2 cases. Surg Obes Relat Dis.
3:195–197. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Müller-Stich BP, Senft JD, Warschkow R,
Kenngott HG, Billeter AT, Vit G, Helfert S, Diener MK, Fischer L,
Büchler MW and Nawroth PP: Surgical versus medical treatment of
type 2 diabetes mellitus in nonseverely obese patients: A
systematic review and meta-analysis. Ann Surg. 261:421–429. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vilsbøll T: On the role of the incretin
hormones GIP and GLP-1 in the pathogenesis of Type 2 diabetes
mellitus. Dan Med Bull. 51:364–370. 2004.PubMed/NCBI
|
|
35
|
Miyawaki K, Yamada Y, Ban N, Ihara Y,
Tsukiyama K, Zhou H, Fujimoto S, Oku A, Tsuda K, Toyokuni S, et al:
Inhibition of gastric inhibitory polypeptide signaling prevents
obesity. Nat Med. 8:738–742. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gault VA, Mcclean PL, Cassidy RS, Irwin N
and Flatt PR: Chemical gastric inhibitory polypeptide receptor
antagonism protects against obesity, insulin resistance, glucose
intolerance and associated disturbances in mice fed high-fat and
cafeteria diets. Diabetologia. 50:1752–1762. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Aylwin S: Gastrointestinal surgery and gut
hormones. Curr Opin Endocrinol Diabetes Obes. 12:89–98. 2005.
View Article : Google Scholar
|
|
38
|
Meirelles K, Ahmed T, Culnan DM, Lynch CJ,
Lang CH and Cooney RN: Mechanisms of glucose homeostasis after
Roux-en-Y gastric bypass surgery in the obese, insulin-resistant
Zucker rat. Ann Surg. 249:277–285. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Patriti A, Facchiano E, Annetti C, Aisa
MC, Galli F, Fanelli C and Donini A: Early improvement of glucose
tolerance after ileal transposition in a non-obese type 2 diabetes
rat model. Obes Surg. 15:1258–1264. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hancock AS, Du A, Liu J, Miller M and May
CL: Glucagon deficiency reduces hepatic glucose production and
improves glucose tolerance in adult mice. Mol Endocrinol.
24:1605–1614. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jecht M: Leptintherapie bei
Typ-1-diabetes-bedingtem insulinmangel. Der Diabetologe. 6:214–216.
2010. View Article : Google Scholar
|
|
42
|
Muñoz MC, Barberà A, Domínguez J,
Fernàndezalvarez J, Gomis R and Guinovart JJ: Effects of tungstate,
a new potential oral antidiabetic agent, in Zucker diabetic fatty
rats. Diabetes. 50:131–138. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zingone A, Hiraiwa H, Pan CJ, Lin B, Chen
H, Ward JM and Chou JY: Correction of glycogen storage disease type
1a in a mouse model by gene therapy. J Biol Chem. 275:828–832.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
White MF: IRS2 integrates insulin/IGF1
signalling with metabolism, neurodegeneration and longevity.
Diabetes Obes Metab. 16 Suppl 1:S4–S15. 2014. View Article : Google Scholar
|
|
45
|
Santamaria B, Marquez E, Lay A, Carew RM,
González-Rodríguez Á, Welsh GI, Ni L, Hale LJ, Ortiz A, Saleem MA,
et al: IRS2 and PTEN are key molecules in controlling insulin
sensitivity in podocytes. Biochim Biophys Acta. 1853:3224–3234.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Patti ME, Houten SM, Bianco AC, Bernier R,
Larsen PR, Holst JJ, Badman MK, Maratos-Flier E, Mun EC,
Pihlajamaki J, et al: Serum bile acids are higher in humans with
prior gastric bypass: Potential contribution to improved glucose
and lipid metabolism. Obesity (Silver Spring). 17:1671–1677. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Withers DJ, Gutierrez JS, Towery H, Burks
DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, et al:
Disruption of IRS-2 causes type 2 diabetes in mice. Nature.
391:900–904. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kubota N, Tobe K, Terauchi Y, Eto K,
Yamauchi T, Suzuki R, Tsubamoto Y, Komeda K, Nakano R, Miki H, et
al: Disruption of insulin receptor substrate 2 causes type 2
diabetes because of liver insulin resistance and lack of
compensatory beta-cell hyperplasia. Diabetes. 49:1880–1889. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Shao J, Yamashita H, Qiao L and Friedman
JE: Decreased Akt kinase activity and insulin resistance in
C57BL/KsJ-Leprdb/db mice. J Endocrinol. 167:107–115. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yamashita H, Shao J, Qiao L, Pagliassotti
M and Friedman JE: Effect of spontaneous gestational diabetes on
fetal and postnatal hepatic insulin resistance in Lepr(db/+) mice.
Pediatr Res. 53:411–418. 2003. View Article : Google Scholar : PubMed/NCBI
|
